| |
| |
|
| Insider
Information: |
Regnante Keith |
| Relationship: |
Chief Financial Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
29,186 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$170,738 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
29,186 |
|
|
| Total
Value |
$170,738 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Wave Life Sciences Ltd. |
WVE |
Chief Financial Officer |
2019-03-07 |
29,186 |
2017-01-25 |
0 |
Premium* |
|
|
Keros Therapeutics, Inc. |
KROS |
Chief Financial Officer |
2023-11-04 |
0 |
2023-06-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KROS |
Keros Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-11-04 |
4 |
AS |
$45.29 |
$1,811,600 |
D/D |
(40,000) |
0 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-11-04 |
4 |
OE |
$16.00 |
$640,000 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-09 |
4 |
AS |
$45.03 |
$908,367 |
D/D |
(20,000) |
0 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-09 |
4 |
OE |
$16.00 |
$320,000 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-08 |
4 |
AS |
$47.66 |
$955,872 |
D/D |
(20,000) |
0 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-08 |
4 |
OE |
$16.00 |
$320,000 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Chief Financial Officer |
• – – |
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
13,500 |
29,186 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Chief Financial Officer |
• – – |
2019-02-19 |
4 |
AS |
$36.84 |
$47,818 |
D/D |
(1,298) |
15,686 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Chief Financial Officer |
• – – |
2018-09-24 |
4 |
AS |
$55.00 |
$1,622,500 |
D/D |
(29,500) |
16,984 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Chief Financial Officer |
• – – |
2018-09-24 |
4 |
OE |
$20.89 |
$616,255 |
D/D |
29,500 |
46,484 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Chief Financial Officer |
• – – |
2018-02-16 |
4 |
AS |
$51.85 |
$16,385 |
D/D |
(316) |
16,984 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Chief Financial Officer |
• – – |
2018-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
17,300 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Chief Financial Officer |
• – – |
2017-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,300 |
4,300 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
